Search

everythinglearnresearchcommunity

for

Search:↓

Increasing Treg cells in the skin does not cure hair loss from alopecia areata in mice.

A woman's hair loss during Hepatitis C treatment with PEG-INF-a-2a and Ribavirin was reversible after stopping the medication.

The article suggests managing interferon beta therapy side effects in MS with dose adjustments, medications, and patient education.

Teriflunomide helps reduce multiple sclerosis symptoms and is safe for most patients.

Peptide hydrogels heal burn wounds faster and better than standard dressings.

Stress increases nerve fibers and immune cell activity in mouse skin, possibly worsening skin conditions.

Certain diets can affect skin conditions, but more research is needed to understand these relationships fully.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Scalp cooling can help prevent chemotherapy-induced hair loss with a 50-90% success rate and is safe for patients.

Some treatments like intralesional steroids and 5α-reductase inhibitors are effective for frontal fibrosing alopecia, but more research is needed.

Trichoscopy is useful for diagnosing and monitoring systemic lupus erythematosus, with certain hair and scalp changes indicating more active disease.

Teriflunomide is effective and generally safe for treating relapsing-remitting multiple sclerosis.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Chronic kidney disease can cause skin problems that affect patient quality of life, and treating these conditions can improve outcomes.

Using systemic drugs as creams for skin conditions shows promise, but more research is needed to confirm their effectiveness and safety.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Chemotherapy and cytokine therapy can cause various skin reactions, including hair loss and hypersensitivity.

Tofacitinib improves nail conditions in patients with severe hair loss and does not affect hair regrowth.

The study found no significant difference in stress hormone levels between people with alopecia areata and healthy individuals, suggesting that the disease is not caused by an overactive stress response system.

Some alternative medicine treatments might work for skin conditions, but their effectiveness and safety differ a lot.

COVID-19 can cause various skin issues, but long-term skin problems are rare.

Baricitinib is a new, effective treatment for advanced alopecia areata but is costly and has risks.

ULBP3 levels are higher in Tinea capitis patients and may help predict the disease's severity.

Up to half of people experience itchy scalp, often due to skin conditions like seborrheic dermatitis or psoriasis, and treatments vary based on the specific cause.

The model and estimator can predict drug exposure in kidney transplant patients well.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

People with advanced chronic kidney disease often have skin problems, which can be treated with various medications and procedures to improve their quality of life.

Targeting Vδ1+T-cells may help treat alopecia areata.

Cyclosporine may cause hair loss, so patients need monitoring.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.